American Vietnamese Biotech (HSTC:AMV) Total Stockholders Equity: ₫0.00 Mil (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is American Vietnamese Biotech Total Stockholders Equity?

American Vietnamese Biotech HSTC:AMV Total Stockholders Equity is ₫0.00 Mil as of . 20.

American Vietnamese Biotech's Total Stockholders Equity for the quarter that ended in . 20 was ₫0.00 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. American Vietnamese Biotech's Book Value per Share for the quarter that ended in . 20 was ₫N/A. The ratio of a company's debt over equity can be used to measure how leveraged this company is. American Vietnamese Biotech's Debt-to-Equity for the quarter that ended in . 20 was .

American Vietnamese Biotech  (HSTC:AMV) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

American Vietnamese Biotech's Book Value per Share for the quarter that ended in . 20 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(-)/0
=N/A

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

American Vietnamese Biotech's Debt-to-Equity for the quarter that ended in . 20 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=( + ) /
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

American Vietnamese Biotech Total Stockholders Equity Related Terms

American Vietnamese Biotech Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for American Vietnamese Biotech's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

American Vietnamese Biotech Total Stockholders Equity Chart

American Vietnamese Biotech Annual Data
Trend
Total Stockholders Equity

American Vietnamese Biotech Quarterly Data
Total Stockholders Equity
What does a Total Stockholders Equity of ₫0.00 Mil mean?
American Vietnamese Biotech (HSTC:AMV) has a Total Stockholders Equity of ₫0.00 Mil as of . 20. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for American Vietnamese Biotech and its competitors.
Is American Vietnamese Biotech's Total Stockholders Equity too high?
American Vietnamese Biotech's current Total Stockholders Equity is ₫0.00 Mil.
How does American Vietnamese Biotech's Total Stockholders Equity compare to HSTC and STLT?
American Vietnamese Biotech's Total Stockholders Equity of ₫0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Biotechnology company?
A good Total Stockholders Equity depends on the Biotechnology industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for American Vietnamese Biotech and its competitors. American Vietnamese Biotech's current Total Stockholders Equity is ₫0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is American Vietnamese Biotech stock overvalued right now?
American Vietnamese Biotech (HSTC:AMV) has a current Total Stockholders Equity of ₫0.00 Mil. The current Total Stockholders Equity is ₫0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For American Vietnamese Biotech (HSTC:AMV), the current Total Stockholders Equity is ₫0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

American Vietnamese Biotech Business Description

Address No. 85 Hoang Van Thai, 4th Floor, Phu Ma Duong Building, Tan Phu Ward, District 7, Ho Chi Minh, VNM
American Vietnamese Biotech Incorporation is engaged in trading in pharmaceuticals, purchasing and selling medical equipment, medical testing instruments, and chemicals; producing and trading vaccines and medical biological products.